Analysis: Europe’s crisis spells more pain for drugmakers – Reuters


Analysis: Europe's crisis spells more pain for drugmakers
Reuters
LONDON (Reuters) – Drugmakers are counting the cost of the deepening euro zone crisis, with further austerity-driven price cuts expected in important European markets, including Italy and France. Growing alarm at multiple
Pharma group protests European pricing painFiercePharma

all 19 news articles »

Pharmaceuticals – Google News